Chimerix, Inc. (CMRX) Announces Third Quarter 2013 Financial Results
11/14/2013 12:52:06 PM
DURHAM, N.C., Nov. 14, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today reported financial results for the quarter ended September 30, 2013.
Help employers find you! Check out all the jobs and post your resume.